| 1st PTH-IMA | First-generation parathyroid hormone immunometric assay |
| 2° HPT | Secondary hyperparathyroidism |
| AIs | Adequate intakes |
| AVN | Avascular necrosis |
| BCG | Bromocresol green method |
| BFR | Bone formation rate |
| BMC | Bone mineral content |
| BMD | Bone mineral density |
| CaR | Calcium-sensing receptors |
| CAPD | Continuous ambulatory peritoneal dialysis |
| CaXP | Calcium-phosphorus product |
| CCR | Creatinine clearance rate |
| CKD | Chronic kidney disease |
| CRF | Chronic renal failure |
| DBP | Vitamin D-binding protein |
| DEXA | Dual energy X-ray absorptiometry |
| DFO | Desferrioxamine |
| DOQI | Dialysis Outcomes Quality Initiative |
| DRI | Dietary Reference Intake |
| EBCT | Electron beam computed tomography |
| EEG | Electroencephalogram |
| ESRD | End-stage renal disease |
| GFR | Glomerular filtration rate |
| GH, rhGH | Growth hormone, recombinant human growth hormone |
| ICMA | Immunochemiluminometric assay |
| IGF | Insulin-like growth factor |
| IRMA | Immunoradiometric assay |
| KDOQI | Kidney Disease Outcomes Quality Initiative |
| MCV | Mean cell volume |
| MDRD | Modification of Diet in Renal Disease |
| MRI | Magnetic resonance imaging |
| NKF | National Kidney Foundation |
| PBM | Peak bone mass |
| PTH | Parathyroid hormone |
| QCT | Quantitative computed tomography |
| RDA | Recommended dietary allowance |
| RDI | Recommended daily intake |
| ROC | Receiver operating characteristics |
| SCFE | Symptomatic proximal femoral slipped epiphyses |
| SD | Standard deviation |
| VDR | Vitamin D receptor |
| VDRE | Vitamin D receptor element, vitamin D-responsive element |